Prime Medicine, Inc.

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total revenue	0.00	0.00	0.00	0.01	0.00	0.01
Cost of revenue	0.01	0.01	0.00	0.01	0.00	0.00	0.00
Gross profit	0.00	0.00	0.00	-0.01	0.00	0.00	0.00
Total operating expenses +	0.21	0.21	0.20	0.12	0.08	0.00	0.00
Selling, general and administrative	0.05	0.05	0.04	0.03	0.01	0.00	0.00
Research and development	0.16	0.16	0.15	0.09	0.07	0.00	0.00
Other operating expenses	-0.01	0.00	0.01	0.00	0.00	0.00	0.00
Operating income	-0.21	-0.20	-0.20	-0.12	-0.08	0.00	0.00
Non-operating income (net)	0.01	0.01	0.01	-0.01	-0.08	0.00	0.00
Income before tax	-0.20	-0.20	-0.20	-0.12	-0.17	0.00	0.00
Income tax expense			0.00	0.00	0.00	0.00	0.00
Net income	-0.20	-0.20	-0.20	-0.12	-0.17	0.00	0.00

Show Quarterly Income Statement

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Dec-19
Total revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.03	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.01
Cost of revenue	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00				0.00	0.00	0.00
Gross profit	0.00	0.00	-0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00				0.00	0.00	0.00
Total operating expenses +	0.05	0.05	0.01	0.05	0.05	0.05	0.05	0.06	0.05	0.07	0.05	0.05	0.04	0.04	0.03	0.03	0.02	0.06	0.01	0.01	0.00	0.00	0.00
Selling, general and administrative	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Research and development	0.03	0.03	0.04	0.04	0.04	0.03	0.04	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	0.02	0.01	0.05	0.01	0.01	0.00	0.00	0.00
Other operating expenses	0.00	0.00	-0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating income	-0.05	-0.05	-0.05	-0.05	-0.05	-0.04	-0.05	-0.06	-0.05	-0.07	-0.05	-0.05	-0.04	-0.04	-0.03	-0.03	-0.02	-0.06	-0.01	-0.01	-0.01	0.00	0.00
Non-operating income (net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.01	-0.08	0.00	0.00
Income before tax	-0.05	-0.05	-0.05	-0.05	-0.05	-0.04	-0.05	-0.06	-0.05	-0.07	-0.05	-0.04	-0.04	-0.04	-0.03	-0.03	-0.02	-0.06	-0.02	0.00	-0.09	0.00	0.00
Income tax expense								0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net income	-0.05	-0.05	-0.05	-0.05	-0.05	-0.04	-0.05	-0.06	-0.05	-0.07	-0.05	-0.04	-0.04	-0.04	-0.04	-0.03	-0.02	-0.06	-0.02	0.00	-0.09	0.00	0.00

5 days ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Total cash and short-term investments +	0.18	0.19	0.12	0.29	0.27	0.05	0.01
Cash and cash equivalents	0.06	0.18	0.04	0.19	0.19	0.04	0.01
Short-term investments	0.11	0.01	0.08	0.11	0.08	0.02
Other current assets	0.00	0.02	0.02	0.00	0.00	0.00	0.00
Total current assets	0.18	0.21	0.14	0.30	0.27	0.05	0.01
Total non-current assets +	0.16	0.09	0.05	0.06	0.03	0.00
Property, plant and equipment, net				0.02	0.02	0.00
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.34	0.30	0.19	0.36	0.30	0.05	0.01

Total current liabilities +	0.04	0.04	0.06	0.03	0.06	0.02	0.01
Accounts payable	0.01	0.01	0.02	0.00	0.00	0.00
Short-term debt	0.01	0.00	0.01	0.01	0.01	0.02
Current portion of long-term debt
Deferred revenue
Other current liabilities	0.01	0.02	0.03	0.01	0.05	0.02	0.01
Total non-current liabilities +	0.18	0.11	0.00	0.02	0.00	0.00
Long-term debt
Capital lease obligations	0.12	0.04	0.01	0.03	0.01	0.00
Other non-current liabilities
Total liabilities	0.22	0.14	0.06	0.04	0.06	0.02	0.01

Total stockholders' equity +	0.12	0.15	0.13	0.32	0.24	0.03	0.00
Common stock and paid-in capital	1.01	0.84	0.62	0.61	0.41	0.04	0.00
Retained earnings	-0.89	-0.69	-0.49	-0.29	-0.17	-0.01	0.00
Common shares outstanding	149	119	91	97	96	96	96

Show Quarterly Balance Sheet

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Dec-19
Total cash and short-term investments +	0.14	0.18	0.21	0.10	0.14	0.19	0.18	0.16	0.21	0.12	0.17	0.21	0.25	0.29	0.15	0.18	0.21	0.27	0.30	0.00	0.05	0.05	0.00
Cash and cash equivalents	0.06	0.06	0.07	0.05	0.09	0.18	0.12	0.06	0.09	0.04	0.04	0.12	0.13	0.19	0.05	0.09	0.16	0.19	0.20		-0.05	0.04
Short-term investments	0.07	0.11	0.14	0.05	0.05	0.01	0.06	0.11	0.12	0.08	0.12	0.09	0.12	0.11	0.10	0.09	0.05	0.08	0.10		0.11	0.02
Accounts receivable, net				0.00	0.00		0.06					0.00	0.00		0.01
Other current assets	0.00	0.00	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.02	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00			0.00
Total current assets	0.14	0.18	0.23	0.12	0.16	0.21	0.25	0.17	0.22	0.14	0.18	0.22	0.25	0.30	0.15	0.18	0.21	0.27	0.30		0.05	0.05
Total non-current assets +	0.16	0.16	0.15	0.16	0.16	0.09	0.09	0.09	0.09	0.05	0.05	0.06	0.06	0.06	0.07	0.07	0.03	0.03	0.01		-0.05	0.00
Property, plant and equipment, net												0.02	0.02	0.02	0.01	0.05	0.02	0.02
Goodwill
Intangible assets
Long-term investments
Other non-current assets
Total assets	0.29	0.34	0.39	0.28	0.33	0.30	0.33	0.26	0.31	0.19	0.24	0.28	0.32	0.36	0.22	0.25	0.24	0.30	0.32			0.05

Total current liabilities +	0.04	0.04	0.04	0.03	0.03	0.04	0.04	0.02	0.02	0.06	0.04	0.03	0.02	0.03	0.02	0.02	0.01	0.06	0.01			0.02
Accounts payable	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.01	0.02	0.01	0.01	0.00	0.00	0.00	0.01	0.00	0.00	0.00			0.00
Short-term debt	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01			0.02
Current portion of long-term debt
Deferred revenue
Other current liabilities	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.01	0.01	0.03	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.05	0.00			0.02
Total non-current liabilities +	0.18	0.18	0.19	0.18	0.19	0.11	0.11	0.04	0.04	0.00	0.01	0.01	0.01	0.02	0.02	0.02	0.00	0.00	0.00			0.00
Long-term debt
Capital lease obligations	0.11	0.12	0.12	0.12	0.12	0.04	0.04	0.04	0.04	0.01	0.02	0.03	0.03	0.03	0.03	0.03		0.01
Other non-current liabilities												0.01	0.01
Total liabilities	0.22	0.22	0.22	0.22	0.22	0.14	0.14	0.06	0.07	0.06	0.05	0.04	0.04	0.04	0.04	0.05	0.02	0.06	0.01			0.02

Total stockholders' equity +	0.08	0.12	0.16	0.06	0.11	0.15	0.19	0.20	0.24	0.13	0.19	0.24	0.28	0.32	0.17	0.20	0.23	0.24	0.30		0.03	0.03
Common stock and paid-in capital	1.01	1.01	1.00	0.85	0.85	0.84	0.83	0.79	0.78	0.62	0.62	0.62	0.61	0.61	0.43	0.43	0.42	0.41	0.41	0.00	0.03	0.04	0.00
Retained earnings	-0.94	-0.89	-0.84	-0.79	-0.74	-0.69	-0.64	-0.59	-0.54	-0.49	-0.43	-0.37	-0.33	-0.29	-0.25	-0.22	-0.20	-0.17	-0.11			-0.01
Common shares outstanding	177	149	161	129	131	119	120	119	104	97	92	90	89	97	97	96	96	96	96	96	96	96	96

5 days ago

Ask a follow up

	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19
Operating cash flow +	-0.16	-0.12	-0.17	-0.13	-0.03	-0.01	0.00
Net income
Depreciation, depletion and amortization	0.01	0.01	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.03	0.03	0.01	0.01	0.00	0.00
Change in inventory
Other working capital changes	-0.20	-0.16	-0.18	-0.14	-0.04	-0.01	0.00
Cash flow from investing +	-0.11	0.07	0.02	-0.05	-0.07	0.00	0.00
Capital expenditures	0.00	-0.01	-0.01	-0.02	0.00	0.00	0.00
Others incl. marketable securities changes	-0.10	0.08	0.03	-0.03	-0.07	0.00	0.00
Cash flow from financing +	0.15	0.20	0.00	0.18	0.27	0.03	0.01
Dividend payout
Common stock repurchases				0.18
Net Debt Issuance	0.15	0.20	0.00	0.00	0.27	0.03	0.01

Change in cash	-0.12	0.14	-0.15	0.00	0.16	0.03	0.01

Show Quarterly Cash Flow

	Mar-26	Dec-25	Sep-25	Jun-25	Mar-25	Dec-24	Sep-24	Jun-24	Mar-24	Dec-23	Sep-23	Jun-23	Mar-23	Dec-22	Sep-22	Jun-22	Mar-22	Dec-21	Sep-21	Jun-21	Mar-21	Dec-20	Dec-19
Operating cash flow +	-0.04	-0.04	-0.04	-0.04	-0.05	0.02	-0.03	-0.05	-0.07	-0.04	-0.04	-0.04	-0.04	-0.03	-0.03	-0.02	-0.05	-0.01	-0.01	-0.01	0.00	0.00	0.00
Net income
Depreciation, depletion and amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Stock-based compensation	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in inventory
Other working capital changes	-0.05	-0.04	-0.05	-0.05	-0.06	0.01	-0.03	-0.06	-0.07	-0.05	-0.04	-0.05	-0.05	-0.03	-0.03	-0.02	-0.05	-0.01	-0.01	-0.01	-0.01	0.00	0.00
Cash flow from investing +	0.04	0.03	-0.09	0.00	-0.05	0.05	0.05	0.01	-0.04	0.04	-0.04	0.03	-0.01	-0.01	-0.01	-0.05	0.03	0.01	-0.01	-0.08	0.00	0.00
Capital expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Others incl. marketable securities changes	0.04	0.03	-0.09	0.00	-0.05	0.05	0.05	0.01	-0.03	0.04	-0.03	0.03	-0.01	-0.01	-0.01	-0.05	0.03	0.01	-0.01	-0.08	0.00	0.00	0.00
Cash flow from financing +	0.00	0.00	0.14	0.00	0.01	0.00	0.04	0.00	0.16	0.00	0.00	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.03	0.01
Dividend payout
Common stock repurchases												0.00	0.00
Net Debt Issuance	0.00	0.00	0.14	0.00	0.01	0.00	0.04	0.00	0.16	0.00	0.00	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.03	0.01

Change in cash	0.00	-0.01	0.02	-0.04	-0.09	0.06	0.06	-0.04	0.05	0.00	-0.08	-0.01	-0.05	0.14	-0.04	-0.07	-0.02	0.00	-0.02	0.18	0.00	0.03	0.01